25 XP   0   0   10

Island Pharmaceuticals Ltd
Buy, Hold or Sell?

Let's analyse Island Pharmaceuticals Ltd together

PenkeI guess you are interested in Island Pharmaceuticals Ltd. Buy, hold or sell? I don't know! However, I do recommend doing research before doing anything. I will help you with that.

I'm going to help you getting a better view of Island Pharmaceuticals Ltd. At the end you don't have to ask anyone for trading advice. You can make your own decision, with more confidence, the odds in your favor, backed by data.

You can find me behind Let's Analyse Together in the top-right of each section.

Get notifications about Island Pharmaceuticals Ltd

I send you an email if I find something interesting about Island Pharmaceuticals Ltd.

Quick analysis of Island Pharmaceuticals Ltd (30 sec.)










What can you expect buying and holding a share of Island Pharmaceuticals Ltd? (30 sec.)

How much money do you get?

How much money do you get?
A$0.00
When do you have the money?
1 year
How often do you get paid?
0.0%

What is your share worth?

Current worth
A$0.02
Expected worth in 1 year
A$-0.07
How sure are you?
25.0%

+ What do you gain per year?

Total Gains per Share
A$-0.09
Return On Investment
-143.6%

For what price can you sell your share?

Current Price per Share
A$0.06
Expected price per share
A$0.055 - A$0.066
How sure are you?
50%

1. Valuation of Island Pharmaceuticals Ltd (5 min.)




Live pricePrice per Share (EOD)

A$0.06

Intrinsic Value Per Share

A$-0.41 - A$-0.49

Total Value Per Share

A$-0.40 - A$-0.48

2. Growth of Island Pharmaceuticals Ltd (5 min.)




Is Island Pharmaceuticals Ltd growing?

Current yearPrevious yearGrowGrow %
How rich?$1.1m$2.7m-$1.6m-141.9%

How much money is Island Pharmaceuticals Ltd making?

Current yearPrevious yearGrowGrow %
Making money-$1.8m-$1.6m-$144.5k-7.9%
Net Profit Margin-25,580.2%0.0%--

How much money comes from the company's main activities?

3. Financial Health of Island Pharmaceuticals Ltd (5 min.)




4. Comparing to competitors in the Biotechnology industry (5 min.)




  Industry Rankings (Biotechnology)  


Richest
#853 / 1020

Most Revenue
#704 / 1020

Most Profit
#286 / 1020

Most Efficient
#982 / 1020

What can you expect buying and holding a share of Island Pharmaceuticals Ltd? (5 min.)

Welcome investor! Island Pharmaceuticals Ltd's management wants to use your money to grow the business. In return you get a share of Island Pharmaceuticals Ltd.

What can you expect buying and holding a share of Island Pharmaceuticals Ltd?

First you should know what it really means to hold a share of Island Pharmaceuticals Ltd. And how you can make/lose money.

Speculation

The Price per Share of Island Pharmaceuticals Ltd is A$0.062. The market price reflects what other people think it is worth; not what it's really worth. Your job is to find out if the market price is fair, overpriced, or underpriced. I will help you with that.

If you buy blind, there is a 50% chance of making or losing money by selling the stock in the future. However, we can look at a few things to determine the odds in our favor:

  • The fundamentals: the financial health trends of Island Pharmaceuticals Ltd.
  • The technials: based on market psychology, we can make a calculated estimate of what the price will do in the future. We can do this through technical analysis. We can calculate the probabilities and the expected value (millionaire math). That's called speculation.
  • The book value: what is the market price compared to it's book value.

Investing

If you really want to invest in Island Pharmaceuticals Ltd, you will have to let go of the thought of selling in the future. If you have to sell the share for less than you bought it, it can still be a good investment. Focus on what it means to hold the stock forever:

  • You own a part of the company. The equity of this part can grow or shrink. The current Book Value per Share is A$0.02. Based on the TTM, the Book Value Change Per Share is A$-0.02 per quarter. Based on the YOY, the Book Value Change Per Share is A$-0.02 per quarter.
  • You may receive quarterly/yearly dividend in the form of additional shares.
  • You may receive quarterly/yearly dividend in the form of cash. Based on the TTM the Dividend per Share is A$0.00 per quarter.
Based on historical numbers we can estimate the returns while holding a share of Island Pharmaceuticals Ltd.

How much money are you going to get?

 MRQTTMYOY5Y10Y
 A$% of Price per ShareA$% of Price per ShareA$% of Price per ShareA$% of Price per ShareA$% of Price per Share
Usd Eps-0.02-25.9%-0.02-25.9%-0.01-23.9%-0.01-17.3%-0.01-17.3%
Usd Book Value Change Per Share-0.01-23.2%-0.01-23.2%-0.01-19.1%0.004.1%0.004.1%
Usd Dividend Per Share0.000.0%0.000.0%0.000.0%0.000.0%0.000.0%
Usd Total Gains Per Share-0.01-23.2%-0.01-23.2%-0.01-19.1%0.004.1%0.004.1%
Usd Price Per Share0.12-0.12-0.16-0.07-0.07-
Price to Earnings Ratio-7.44--7.44--11.13--4.64--4.64-
Price-to-Total Gains Ratio-8.31--8.31--13.94--11.13--11.13-
Price to Book Ratio11.79-11.79-6.72-4.63-4.63-
Price-to-Total Gains Ratio-8.31--8.31--13.94--11.13--11.13-

When do you get the money?

Usd Investment
$.00
Usd Price Per Share0.0400954
Number of shares24940
Gains per QuarterTrailing 12 Months5 Year
Usd Dividend Per Share0.000.00
Usd Book Value Change Per Share-0.010.00
Usd Total Gains Per Share-0.010.00
Gains per Quarter (24940 shares)-359.0463.27
Gains per Year (24940 shares)-1,436.17253.09
YearsReturn on Investment (TTM)Return on Investment (5Y)
 DividendBook Value gainTotal gainsDividendBook Value gainTotal gains
Broker costs---10---10
10-1436-14460253243
20-2872-28820506496
30-4308-43180759749
40-5745-5754010121002
50-7181-7190012651255
60-8617-8626015191508
70-10053-10062017721761
80-11489-11498020252014
90-12925-12934022782267
100-14362-14370025312520

How sure are you?

Based on the past periods, how sure are you to get value out of your investment.

Linear %
 Trailing 12 Months3Y5 Year10 YearALLTIME
  % % % % %
Earnings Per Share0.01.00.00.0%0.03.00.00.0%0.04.00.00.0%0.04.00.00.0%0.04.00.00.0%
Book Value Change Per Share0.01.00.00.0%1.02.00.033.3%1.03.00.025.0%1.03.00.025.0%1.03.00.025.0%
Dividend per Share0.00.01.00.0%0.00.03.00.0%0.00.04.00.0%0.00.04.00.0%0.00.04.00.0%
Total Gains per Share0.01.00.00.0%1.02.00.033.3%1.03.00.025.0%1.03.00.025.0%1.03.00.025.0%

Fundamentals of Island Pharmaceuticals Ltd

About Island Pharmaceuticals Ltd

Island Pharmaceuticals Limited, a drug research and repurposing company, focuses on the development of preventative or therapeutic drugs for viral infections. Its lead product candidate is ISLA-101, a drug for the prevention and treatment of dengue fever and other mosquito borne diseases. The company has a research collaboration agreement with Monash University to screen known molecules against host targets; research and development collaboration with Griffith University to screen for active anti-viral molecules in a rational repurposing strategy; and research collaboration agreement with Compounds Australia, a drug library containing various molecules that could be searched for drug re-purposing and pipeline development. It also has a cooperative research and development agreement with the U.S. Army in preparation for its Phase II clinical study for ISLA-101; supply agreement with Catalent for manufacture of Fenretinide softgels for dengue fever trial participants; and right to reference National Cancer Institute IND for Isla101. The company was incorporated in 2020 and is based in Camberwell, Australia.

Fundamental data was last updated by Penke on 2024-03-31 21:27:03.

Financial Health

Profitability Details
 Compared to previous yearCompared to industry
The company is making a huge loss.
Using its assets, the company is very inefficient in making profit.
Using its investors money, the company is very inefficient in making profit.
Operating Efficiency Details
 Compared to previous yearCompared to industry
The company is operating very inefficient.
The company is inefficient in keeping operating costs low.
Liquidity Details
 Compared to previous yearCompared to industry
The company is very able to pay all its short-term debts.
The company is very able to pay all its short-term debts with the most liquid assets.
Solvency Details
 Compared to previous yearCompared to industry
The company is very able to pay all its debts by selling its assets.
The company is very able to pay all its debts with equity.

Valuation

Valuation Details
 Compared to previous yearCompared to industry
Based on the equity, the company is expensive.
Based on the earnings, the company is expensive.
Based on how much money comes from the company's main activities, the company is expensive.

1.1. Profitability of Island Pharmaceuticals Ltd.

1.1. Profitability
1.1.1. Net Profit Margin

Measures how much net profit Island Pharmaceuticals Ltd earns for each $1 of revenue.

  • Above 10% is considered healthy but always compare Island Pharmaceuticals Ltd to the Biotechnology industry mean.
  • A Net Profit Margin of -25,580.2% means that $-255.80 for each $1 in revenue is generated as profit.

Let's take a look of the Net Profit Margin trends of Island Pharmaceuticals Ltd:

  • The MRQ is -25,580.2%. The company is making a huge loss. -2
  • The TTM is -25,580.2%. The company is making a huge loss. -2
Trends
Current periodCompared to+/- 
MRQ-25,580.2%TTM-25,580.2%0.0%
TTM-25,580.2%YOY--25,580.2%
TTM-25,580.2%5Y-6,395.0%-19,185.1%
5Y-6,395.0%10Y-6,395.0%0.0%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ-25,580.2%-206.1%-25,374.1%
TTM-25,580.2%-214.1%-25,366.1%
YOY--279.3%+279.3%
5Y-6,395.0%-457.4%-5,937.6%
10Y-6,395.0%-634.2%-5,760.8%
1.1.2. Return on Assets

Shows how efficient Island Pharmaceuticals Ltd is using its assets to generate profit.

  • Above 5% is considered healthy but always compare Island Pharmaceuticals Ltd to the Biotechnology industry mean.
  • -138.1% Return on Assets means that Island Pharmaceuticals Ltd generated $-1.38 profit for each $1 in assets.

Let's take a look of the Return on Assets trends of Island Pharmaceuticals Ltd:

  • The MRQ is -138.1%. Using its assets, the company is very inefficient in making profit. -2
  • The TTM is -138.1%. Using its assets, the company is very inefficient in making profit. -2
Trends
Current periodCompared to+/- 
MRQ-138.1%TTM-138.1%0.0%
TTM-138.1%YOY-53.2%-84.9%
TTM-138.1%5Y-1,023.5%+885.4%
5Y-1,023.5%10Y-1,023.5%0.0%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ-138.1%-14.8%-123.3%
TTM-138.1%-14.1%-124.0%
YOY-53.2%-12.8%-40.4%
5Y-1,023.5%-16.0%-1,007.5%
10Y-1,023.5%-17.6%-1,005.9%
1.1.3. Return on Equity

Shows how efficient Island Pharmaceuticals Ltd is using its investors money to generate profit.

  • Above 15%-20% is considered healthy but always compare Island Pharmaceuticals Ltd to the Biotechnology industry mean.
  • -158.5% Return on Equity means Island Pharmaceuticals Ltd generated $-1.59 for each $1 the owners (shareholders) invested.

Let's take a look of the Return on Equity trends of Island Pharmaceuticals Ltd:

  • The MRQ is -158.5%. Using its investors money, the company is very inefficient in making profit. -2
  • The TTM is -158.5%. Using its investors money, the company is very inefficient in making profit. -2
Trends
Current periodCompared to+/- 
MRQ-158.5%TTM-158.5%0.0%
TTM-158.5%YOY-60.4%-98.2%
TTM-158.5%5Y-63.0%-95.5%
5Y-63.0%10Y-63.0%0.0%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ-158.5%-18.4%-140.1%
TTM-158.5%-16.9%-141.6%
YOY-60.4%-17.9%-42.5%
5Y-63.0%-21.9%-41.1%
10Y-63.0%-23.1%-39.9%

1.2. Operating Efficiency of Island Pharmaceuticals Ltd.

1.2. Operating Efficiency
1.2.1. Operating Margin

Measures how efficient Island Pharmaceuticals Ltd is operating .

  • Measures how much profit Island Pharmaceuticals Ltd makes for each $1 of sales after paying variable costs (production costs, wages, etc) but before taxes.
  • Above 15% is considered healthy but always compare Island Pharmaceuticals Ltd to the Biotechnology industry mean.
  • An Operating Margin of -52,464.5% means the company generated $-524.64  for each $1 in revenue (before taxes).

Let's take a look of the Operating Margin trends of Island Pharmaceuticals Ltd:

  • The MRQ is -52,464.5%. The company is operating very inefficient. -2
  • The TTM is -52,464.5%. The company is operating very inefficient. -2
Trends
Current periodCompared to+/- 
MRQ-52,464.5%TTM-52,464.5%0.0%
TTM-52,464.5%YOY--52,464.5%
TTM-52,464.5%5Y-13,116.1%-39,348.4%
5Y-13,116.1%10Y-13,116.1%0.0%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ-52,464.5%-287.7%-52,176.8%
TTM-52,464.5%-242.2%-52,222.3%
YOY--288.4%+288.4%
5Y-13,116.1%-480.7%-12,635.4%
10Y-13,116.1%-637.5%-12,478.6%
1.2.2. Operating Ratio

Measures how efficient Island Pharmaceuticals Ltd is keeping operating costs low.

  • Below 1 is considered healthy (always compare to Biotechnology industry mean).
  • An Operation Ratio of 262.82 means that the operating costs are $262.82 for each $1 in net sales.

Let's take a look of the Operating Ratio trends of Island Pharmaceuticals Ltd:

  • The MRQ is 262.823. The company is inefficient in keeping operating costs low. -1
  • The TTM is 262.823. The company is inefficient in keeping operating costs low. -1
Trends
Current periodCompared to+/- 
MRQ262.823TTM262.8230.000
TTM262.823YOY-+262.823
TTM262.8235Y65.706+197.117
5Y65.70610Y65.7060.000
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ262.8233.230+259.593
TTM262.8233.283+259.540
YOY-3.832-3.832
5Y65.7065.741+59.965
10Y65.7067.992+57.714

1.3. Liquidity of Island Pharmaceuticals Ltd.

1.3. Liquidity
1.3.1. Current Ratio

Measures if Island Pharmaceuticals Ltd is able to pay off Short-term Debt.

  • Above 1.5 is considered healthy (always compare to Biotechnology industry mean).
  • A Current Ratio of 7.77 means the company has $7.77 in assets for each $1 in short-term debts.

Let's take a look of the Current Ratio trends of Island Pharmaceuticals Ltd:

  • The MRQ is 7.767. The company is very able to pay all its short-term debts. +2
  • The TTM is 7.767. The company is very able to pay all its short-term debts. +2
Trends
Current periodCompared to+/- 
MRQ7.767TTM7.7670.000
TTM7.767YOY8.436-0.669
TTM7.7675Y11.062-3.295
5Y11.06210Y11.0620.000
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ7.7673.986+3.781
TTM7.7674.269+3.498
YOY8.4365.498+2.938
5Y11.0625.971+5.091
10Y11.0626.408+4.654
1.3.2. Quick Ratio

Measures if Island Pharmaceuticals Ltd is able to pay off Short-term Debt but only using the most liquid assets.

  • Above 1 is considered healthy but always compare Island Pharmaceuticals Ltd to the Biotechnology industry mean.
  • A Quick Ratio of 7.64 means the company can pay off $7.64 for each $1 in debt (using most liquid assets).

Let's take a look of the Quick Ratio trends of Island Pharmaceuticals Ltd:

  • The MRQ is 7.639. The company is very able to pay all its short-term debts with the most liquid assets. +2
  • The TTM is 7.639. The company is very able to pay all its short-term debts with the most liquid assets. +2
Trends
Current periodCompared to+/- 
MRQ7.639TTM7.6390.000
TTM7.639YOY8.280-0.641
TTM7.6395Y10.868-3.229
5Y10.86810Y10.8680.000
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ7.6393.757+3.882
TTM7.6394.124+3.515
YOY8.2805.504+2.776
5Y10.8685.943+4.925
10Y10.8686.225+4.643

1.4. Solvency of Island Pharmaceuticals Ltd.

1.3. Liquidity
1.4.1. Debt to Asset Ratio

Measures how much % of Island Pharmaceuticals Ltd assets are financed with debt.

  • Below 1 (100%) is considered healthy but always compare Island Pharmaceuticals Ltd to Biotechnology industry mean.
  • A Debt to Asset Ratio of 0.13 means that Island Pharmaceuticals Ltd assets are financed with 12.9% credit (debt) and the remaining percentage (100% - 12.9%) is financed by its owners/shareholders. 

Let's take a look of the Debt to Asset Ratio trends of Island Pharmaceuticals Ltd:

  • The MRQ is 0.129. The company is very able to pay all its debts by selling its assets. +2
  • The TTM is 0.129. The company is very able to pay all its debts by selling its assets. +2
Trends
Current periodCompared to+/- 
MRQ0.129TTM0.1290.000
TTM0.129YOY0.119+0.010
TTM0.1295Y9.983-9.854
5Y9.98310Y9.9830.000
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ0.1290.328-0.199
TTM0.1290.326-0.197
YOY0.1190.266-0.147
5Y9.9830.370+9.613
10Y9.9830.396+9.587
1.4.2. Debt to Equity Ratio

Measures if Island Pharmaceuticals Ltd is able to pay off its debts by using shareholders equity.

  • Below 2 is considered healthy but always compare Island Pharmaceuticals Ltd to the Biotechnology industry mean.
  • A Debt to Equity ratio of 14.8% means that company has $0.15 debt for each $1 in shareholders equity.

Let's take a look of the Debt to Equity Ratio trends of Island Pharmaceuticals Ltd:

  • The MRQ is 0.148. The company is very able to pay all its debts with equity. +2
  • The TTM is 0.148. The company is very able to pay all its debts with equity. +2
Trends
Current periodCompared to+/- 
MRQ0.148TTM0.1480.000
TTM0.148YOY0.134+0.013
TTM0.1485Y0.080+0.068
5Y0.08010Y0.0800.000
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ0.1480.371-0.223
TTM0.1480.384-0.236
YOY0.1340.328-0.194
5Y0.0800.423-0.343
10Y0.0800.450-0.370

2. Market Valuation of Island Pharmaceuticals Ltd

2.1. Earnings Per Share
2.1. Price to Earnings Ratio

Measures how much money you pay for each share for every $1 in earnings Island Pharmaceuticals Ltd generates.

  • Above 15 is considered overpriced but always compare Island Pharmaceuticals Ltd to the Biotechnology industry mean.
  • A PE ratio of -7.44 means the investor is paying $-7.44 for every $1 in earnings.

Let's take a look of the Price to Earnings Ratio trends of Island Pharmaceuticals Ltd:

  • The EOD is -2.492. Based on the earnings, the company is expensive. -2
  • The MRQ is -7.436. Based on the earnings, the company is expensive. -2
  • The TTM is -7.436. Based on the earnings, the company is expensive. -2
Trends
Current periodCompared to+/- 
EOD-2.492MRQ-7.436+4.944
MRQ-7.436TTM-7.4360.000
TTM-7.436YOY-11.129+3.693
TTM-7.4365Y-4.641-2.795
5Y-4.64110Y-4.6410.000
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
EOD-2.492-2.543+0.051
MRQ-7.436-2.591-4.845
TTM-7.436-2.669-4.767
YOY-11.129-4.234-6.895
5Y-4.641-6.310+1.669
10Y-4.641-6.212+1.571
2.2. Price To Free Cash Flow Ratio

Let's take a look of the Price To Free Cash Flow Ratio trends of Island Pharmaceuticals Ltd:

  • The EOD is -2.604. Based on how much money comes from the company's main activities, the company is expensive. -2
  • The MRQ is -7.771. Based on how much money comes from the company's main activities, the company is expensive. -2
  • The TTM is -7.771. Based on how much money comes from the company's main activities, the company is expensive. -2
Trends
Current periodCompared to+/- 
EOD-2.604MRQ-7.771+5.166
MRQ-7.771TTM-7.7710.000
TTM-7.771YOY-15.452+7.681
TTM-7.7715Y-5.806-1.965
5Y-5.80610Y-5.8060.000
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
EOD-2.604-3.382+0.778
MRQ-7.771-3.363-4.408
TTM-7.771-3.653-4.118
YOY-15.452-5.822-9.630
5Y-5.806-8.477+2.671
10Y-5.806-8.811+3.005
2. Book Value per Share
2.3. Price to Book Ratio

Measures if the stock price of Island Pharmaceuticals Ltd is to cheap or to expensive compared to its book value.

  • At or below 1 is considered healthy (always compare to Biotechnology industry mean).
  • A PB ratio of 11.79 means the investor is paying $11.79 for each $1 in book value.

Let's take a look of the Price to Book Ratio trends of Island Pharmaceuticals Ltd:

  • The EOD is 3.951. Based on the equity, the company is fair priced.
  • The MRQ is 11.789. Based on the equity, the company is expensive. -2
  • The TTM is 11.789. Based on the equity, the company is expensive. -2
Trends
Current periodCompared to+/- 
EOD3.951MRQ11.789-7.838
MRQ11.789TTM11.7890.000
TTM11.789YOY6.719+5.071
TTM11.7895Y4.627+7.162
5Y4.62710Y4.6270.000
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
EOD3.9512.030+1.921
MRQ11.7892.133+9.656
TTM11.7892.124+9.665
YOY6.7192.943+3.776
5Y4.6273.477+1.150
10Y4.6273.682+0.945
2. Total Gains per Share

3. Summary

3.1. Key Performance Indicators

The key performance indicators of Island Pharmaceuticals Ltd compared to the Most Recent Quarter (MRQ).

 End of day+/-Most Recent QuarterTrailing 12 Months+/-Year-Over-Year+/-5 Year+/-10 Year+/-
Book Value Change Per Share---0.022-0.0220%-0.018-18%0.004-667%0.004-667%
Book Value Per Share--0.0160.0160%0.038-59%0.027-43%0.027-43%
Current Ratio--7.7677.7670%8.436-8%11.062-30%11.062-30%
Debt To Asset Ratio--0.1290.1290%0.119+9%9.983-99%9.983-99%
Debt To Equity Ratio--0.1480.1480%0.134+10%0.080+85%0.080+85%
Dividend Per Share----0%-0%-0%-0%
Eps---0.025-0.0250%-0.023-8%-0.017-33%-0.017-33%
Free Cash Flow Per Share---0.024-0.0240%-0.017-31%-0.012-49%-0.012-49%
Free Cash Flow To Equity Per Share---0.025-0.0250%-0.018-29%0.019-232%0.019-232%
Gross Profit Margin--1.0581.0580%1.000+6%1.014+4%1.014+4%
Intrinsic Value_10Y_max---0.494--------
Intrinsic Value_10Y_min---0.412--------
Intrinsic Value_1Y_max---0.023--------
Intrinsic Value_1Y_min---0.023--------
Intrinsic Value_3Y_max---0.090--------
Intrinsic Value_3Y_min---0.085--------
Intrinsic Value_5Y_max---0.181--------
Intrinsic Value_5Y_min---0.165--------
Market Cap7054112.000-198%21048560.00021048560.0000%29012880.000-27%12515360.000+68%12515360.000+68%
Net Profit Margin---255.802-255.8020%--100%-63.950-75%-63.950-75%
Operating Margin---524.645-524.6450%--100%-131.161-75%-131.161-75%
Operating Ratio--262.823262.8230%-+100%65.706+300%65.706+300%
Pb Ratio3.951-198%11.78911.7890%6.719+75%4.627+155%4.627+155%
Pe Ratio-2.492+66%-7.436-7.4360%-11.129+50%-4.641-38%-4.641-38%
Price Per Share0.062-198%0.1850.1850%0.255-27%0.110+68%0.110+68%
Price To Free Cash Flow Ratio-2.604+66%-7.771-7.7710%-15.452+99%-5.806-25%-5.806-25%
Price To Total Gains Ratio-2.785+66%-8.310-8.3100%-13.942+68%-11.126+34%-11.126+34%
Quick Ratio--7.6397.6390%8.280-8%10.868-30%10.868-30%
Return On Assets---1.381-1.3810%-0.532-61%-10.235+641%-10.235+641%
Return On Equity---1.585-1.5850%-0.604-62%-0.630-60%-0.630-60%
Total Gains Per Share---0.022-0.0220%-0.018-18%0.004-667%0.004-667%
Usd Book Value--1154600.7191154600.7190%2792543.078-59%2021250.988-43%2021250.988-43%
Usd Book Value Change Per Share---0.014-0.0140%-0.012-18%0.003-667%0.003-667%
Usd Book Value Per Share--0.0100.0100%0.025-59%0.018-43%0.018-43%
Usd Dividend Per Share----0%-0%-0%-0%
Usd Eps---0.016-0.0160%-0.015-8%-0.011-33%-0.011-33%
Usd Free Cash Flow---1751755.739-1751755.7390%-1214268.495-31%-893197.950-49%-893197.950-49%
Usd Free Cash Flow Per Share---0.015-0.0150%-0.011-31%-0.008-49%-0.008-49%
Usd Free Cash Flow To Equity Per Share---0.016-0.0160%-0.012-29%0.012-232%0.012-232%
Usd Market Cap4561894.230-198%13612103.75213612103.7520%18762629.496-27%8093683.312+68%8093683.312+68%
Usd Price Per Share0.040-198%0.1200.1200%0.165-27%0.071+68%0.071+68%
Usd Profit---1830451.368-1830451.3680%-1685873.823-8%-1223030.795-33%-1223030.795-33%
Usd Revenue--7155.7367155.7360%-+100%1788.934+300%1788.934+300%
Usd Total Gains Per Share---0.014-0.0140%-0.012-18%0.003-667%0.003-667%
 EOD+3 -5MRQTTM+0 -0YOY+4 -305Y+10 -2410Y+10 -24

3.2. Fundamental Score

Let's check the fundamental score of Island Pharmaceuticals Ltd based on Penke's default stock scanner.

Penke's Stock Scanner

  
  
IndicatorConditionValue
Price to Earnings Ratio (EOD)Between0-15-2.492
Price to Book Ratio (EOD)Between0-13.951
Net Profit Margin (MRQ)Greater than0-255.802
Operating Margin (MRQ)Greater than0-524.645
Quick Ratio (MRQ)Greater than17.639
Current Ratio (MRQ)Greater than17.767
Debt to Asset Ratio (MRQ)Less than10.129
Debt to Equity Ratio (MRQ)Less than10.148
Return on Equity (MRQ)Greater than0.15-1.585
Return on Assets (MRQ)Greater than0.05-1.381
Total4/10 (40.0%)

3.3. Technical Score

Let's check the technical score of Island Pharmaceuticals Ltd based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5042.759
Ma 20Greater thanMa 500.062
Ma 50Greater thanMa 1000.073
Ma 100Greater thanMa 2000.078
OpenGreater thanClose0.064
Total1/5 (20.0%)



Latest Balance Sheet

Balance Sheet of 2022-12-31. Currency in AUD. All numbers in thousands.

Summary
Total Assets2,049
Total Liabilities264
Total Stockholder Equity1,785
 As reported
Total Liabilities 264
Total Stockholder Equity+ 1,785
Total Assets = 2,049

Assets

Total Assets2,049
Total Current Assets2,049
Long-term Assets0
Total Current Assets
Cash And Cash Equivalents 1,998
Net Receivables 17
Other Current Assets 34
Total Current Assets  (as reported)2,049
Total Current Assets  (calculated)2,049
+/-0
Long-term Assets
Long-term Assets  (as reported)0
Long-term Assets  (calculated)0
+/-0

Liabilities & Shareholders' Equity

Total Current Liabilities264
Long-term Liabilities0
Total Stockholder Equity1,785
Total Current Liabilities
Accounts payable 113
Other Current Liabilities 151
Total Current Liabilities  (as reported)264
Total Current Liabilities  (calculated)264
+/-0
Long-term Liabilities
Long-term Liabilities  (as reported)0
Long-term Liabilities  (calculated)0
+/-0
Total Stockholder Equity
Common Stock19,901
Retained Earnings -19,763
Other Stockholders Equity 1,648
Total Stockholder Equity (as reported)1,785
Total Stockholder Equity (calculated)1,785
+/-0
Other
Capital Stock19,901
Cash and Short Term Investments 1,998
Common Stock Shares Outstanding 87,520
Liabilities and Stockholders Equity 2,049
Net Debt -1,998
Net Invested Capital 1,785
Net Tangible Assets 1,785
Net Working Capital 1,785



Balance Sheet

Currency in AUD. All numbers in thousands.

 Trend2022-12-312021-12-312020-12-312019-12-31
> Total Assets 
0
6,636
4,899
2,049
2,0494,8996,6360
   > Total Current Assets 
0
6,636
4,899
2,049
2,0494,8996,6360
       Cash And Cash Equivalents 
0
6,461
4,787
1,998
1,9984,7876,4610
       Net Receivables 
0
59
21
17
1721590
   > Long-term Assets 0000
       Other Assets 
0
314
0
0
003140
> Total Liabilities 
1
237
581
264
2645812371
   > Total Current Liabilities 
1
237
581
264
2645812371
       Accounts payable 
134
82
241
113
11324182134
       Other Current Liabilities 
1
155
340
151
1513401551
   > Long-term Liabilities 0000
       Deferred Long Term Liability 
0
314
0
0
003140
> Total Stockholder Equity
-1
6,399
4,318
1,785
1,7854,3186,399-1
   Common Stock
0
19,826
19,901
19,901
19,90119,90119,8260
   Retained Earnings -19,763-4,734-2,127-1
   Capital Surplus 0000
   Treasury Stock0000
   Other Stockholders Equity 
0
-11,299
-10,848
1,648
1,648-10,848-11,2990



Balance Sheet

Currency in AUD. All numbers in thousands.




Cash Flow

Currency in AUD. All numbers in thousands.




Income Statement

Currency in AUD. All numbers in thousands.


Latest Income Statement (annual, 2022-12-31)

Gross Profit (+$)
totalRevenue11
Cost of Revenue-0
Gross Profit1111
 
Operating Income (+$)
Gross Profit11
Operating Expense-2,908
Operating Income-2,908-2,897
 
Operating Expense (+$)
Research Development1,141
Selling General Administrative1,605
Selling And Marketing Expenses163
Operating Expense2,9082,908
 
Net Interest Income (+$)
Interest Income67
Interest Expense-9
Other Finance Cost-67
Net Interest Income-9
 
Pretax Income (+$)
Operating Income-2,908
Net Interest Income-9
Other Non-Operating Income Expenses0
Income Before Tax (EBT)-2,830-2,986
EBIT - interestExpense = -5,814
-5,728
-2,821
Interest Expense9
Earnings Before Interest and Taxes (EBIT)-5,805-2,821
Earnings Before Interest and Taxes (EBITDA)-2,908
 
After tax Income (+$)
Income Before Tax-2,830
Tax Provision-0
Net Income From Continuing Ops-2,830-2,830
Net Income-2,830
Net Income Applicable To Common Shares-2,830
 
Non-recurring Events
Discontinued Operations0
Extraordinary Items0
Effect of Accounting Charges0
Other Items0
Non Recurring0
Other Operating Expenses2,908
Total Other Income/Expenses Net789
 

Technical Analysis of Island Pharmaceuticals Ltd
The psychology behind the price

Technical indicators reflecting market sentiment and the collective psychology of you and other traders. Your emotions and other traders' emotions, such as fear and greed, play a significant role in driving price movements.

General trend

First of all, I'm going to put something in the back of your mind. One of the most stable factors that gives you more confidence as a trader: the general trend of Island Pharmaceuticals Ltd. The general trend of Island Pharmaceuticals Ltd is BEARISH with 100.0% confidence. It is very important for your mental being to use each indicator with this in mind. But beware, also the general trend flips once in a while! You can use moving averages to determine Island Pharmaceuticals Ltd's overall trend. For convenience I use the most commonly used moving averages: 20, 50, 100 & 200. Of course you can use other moving averages or other indicators to determine the trend.

Indicator phases

Some of the indicators I use have 3 zones: overbought, oversold and neutral. Transitions between these zones (market phases) provide valuable trading signals and insights. Expecially with the general trend mind, I use the highlighted phases:

Indicator zone transitionsBullish trend (-100.0%) Bearish trend (100.0%)
Overbought to neutralBullish pullback=Bearish reversal
Upper to lower neutralBullish correction=Bearish continuation
Nuetral to oversoldOversold=Oversold
Oversold to neutralBullish reversal=Bearish correction
Lower to upper neutralBullish continuation=Bearish pullback
Nuetral to overboughtOverbought=Overbought

1. Price Targets

1.1 Support & Resistance

Support and resistance are levels on a price chart that act as barriers or zones where the price of an asset tends to stop, reverse, or experience a significant amount of buying or selling pressure.

Support is a price level at which demand for an asset is strong enough to prevent the price from falling further.
Resistance is a price level at which selling pressure becomes significant enough to prevent the price of an asset from rising further.


Score

Let's take a look at the Support & Resistance of Island Pharmaceuticals Ltd.

The long score for the Support & Resistance is 0/1.
The longshort score for the Support & Resistance is 0/(-1 +1).

  • Between support/resistance: The price is trading between support and resistance lines.

The bullish price targets are: 0.066 < 0.066 < 0.066.

The bearish price targets are: 0.055.

Tweet this
Island Pharmaceuticals Ltd Daily Support & Resistance Chart

2. Trend Indicators

2.1 Moving Averages

Shows the moving average of the selected period.

  • Moving averages are lagging trend indicators.
  • There are many types of moving averages.
  • Moving averages are also used within other indicators.

Score

Let's take a look at the Moving Averages of Island Pharmaceuticals Ltd. The current mas is .

The long score for the Moving Averages is 0/14.
The longshort score for the Moving Averages is -14/(-14 +14).

  • MA 20 trending down: The MA 20 is trending down. -1
  • Close < MA 20: The price is below the MA 20. -1
  • MA 20 < MA 50: The MA 20 is lower than the MA 50. -1
  • MA 20 < MA 100: The MA 20 is lower than the MA 100. -1
  • MA 20 < MA 200: The MA 20 is lower than the MA 200. -1
  • MA 50 trending down: The MA 50 is trending down. -1
  • Close < MA 50: The price is below the MA 50. -1
  • MA 50 < MA 100: The MA 50 is lower than the MA 100. -1
  • MA 50 < MA 200: The MA 50 is lower than the MA 200. -1
  • MA 100 trending down: The MA 100 is trending down. -1
  • Close < MA 100: The price is below the MA 100. -1
  • MA 100 < MA 200: The MA 100 is lower than the MA 200. -1
  • MA 200 trending down: The MA 200 is trending down. -1
  • Close < MA 200: The price is below the MA 200. -1

Directionalities and relatives.

Moving AverageAmount of candlesTrendPrice +/-vs. MA 50vs. MA 100vs. MA 200
MA 2020
MA 5050-
MA 100100--
MA 200200---

Explanation: https://www.youtube.com/watch?v=xwW8h0lrQ-I

Island Pharmaceuticals Ltd Daily Moving Averages Chart
2.2 Moving Average Convergence/Divergence (MACD)

Shows the momentum of the selected period based on two moving averages.

  • MACD is a lagging momentum indicator.
  • Uses two moving averages.
  • Can show buy or sell signals based on momentum.
  • Can show overbought. and oversold. levels.

Score

Let's take a look at the Moving Average Convergence/Divergence (MACD) of Island Pharmaceuticals Ltd. The current macd is -0.00221262.

The long score for the Moving Average Convergence/Divergence (MACD) is 3/4.
The longshort score for the Moving Average Convergence/Divergence (MACD) is 2/(-4 +4).

  • MACD line > signal line: The MACD line is above the signal line, which indicates a bullish signal in the market. This means that the positive momentum is currently stronger than the average momentum, suggesting that buyers are more active than sellers, and there's a higher probability of the Island Pharmaceuticals Ltd price going up in the near term. +2
  • MACD < 0: The MACD is below the zero line (centerline), it indicates a bearish signal for Island Pharmaceuticals Ltd. This means that the short-term moving average is lower than the long-term moving average, signaling negative momentum and suggesting a higher likelihood of the Island Pharmaceuticals Ltd price continuing to fall in the near future. It indicates that sellers are gaining control, and there is negativism in the market, leading to potential price decreases. -1
  • Trending up: The MACD line is trending up. This indicates that the short-term moving average is rising faster than the long-term moving average, suggesting positive momentum in the market. This signals that buyers are becoming more active and confident, leading to potential price increases as traders anticipate further gains and are willing to buy at higher prices. +1
Island Pharmaceuticals Ltd Daily Moving Average Convergence/Divergence (MACD) ChartIsland Pharmaceuticals Ltd Daily Moving Average Convergence/Divergence (MACD) Chart
2.3 Directional Movement Index (DMI)

The DMI is a collection of 3 indicators: +DI (Plus Direction Indicator), -DI (Minus Direction Indicator) and ADX (Average Directional Index). The ADX helps you determine the strength of a trend.


Score

Let's take a look at the Directional Movement Index (DMI) of Island Pharmaceuticals Ltd. The current adx is 13.30.

The long score for the Directional Movement Index (DMI) is 0/7.
The longshort score for the Directional Movement Index (DMI) is -1/(-7 +7).

  • PLUS_ID < MINUS_DI: The +DI line is below the -DI line. This indicates a bearish signal in the market, as the negative directional movement is currently stronger than the positive directional movement, showing that sellers have the upper hand. Market psychology suggests that traders are pessimistic, expecting further price decreases, and are more willing to sell Island Pharmaceuticals Ltd shares, leading to potential downward momentum in its price. -1
  • PLUS_ID < MINUS_DI && ADX < 25 && ADX trending down: The ADX is below 25 and indicates a weak or no trend. Also, the ADX is declining so there is no trend indication.
Island Pharmaceuticals Ltd Daily Directional Movement Index (DMI) Chart
2.4 Parabolic SAR

Shows the current trend and potential entry and exit signals.

  • Parabolic SAR (stop and reverse) is a lagging trend indicator.
  • Shows the current trend.
  • Shows potential entry signals.
  • Shows  potential exit signals.
  • Can be used to place trailing stoplosses..

Score

Let's take a look at the Parabolic SAR of Island Pharmaceuticals Ltd. The current sar is 0.0554356.

The long score for the Parabolic SAR is 1/1.
The longshort score for the Parabolic SAR is 1/(-1 +1).

  • Close > SAR: The price is above the SAR. It's generally considered a bullish signal. +1
Island Pharmaceuticals Ltd Daily Parabolic SAR Chart

3. Momentum Indicators

3.1 Relative Strength Index (RSI)

Measures the speed and change of price movements.

  • Leading momentum indicator, meaning the signals are instant.
  • Ranges between 0 and 100.
  • Above 70 is considered overbought.
  • Below 30 is considered oversold.
  • Above or below 50 can also be used to determine price trend or support and resistance.
  • RSI divergence looks at a deviation between RSI and price movement. Penketrading automatically calculates RSI divergences.
  • Can be used in many different ways

Score

Let's take a look at the Relative Strength Index (RSI) of Island Pharmaceuticals Ltd. The current rsi is 42.76. The current phase is Continuation in bear market.

The long score for the Relative Strength Index (RSI) is 0/13.
The longshort score for the Relative Strength Index (RSI) is -4/(-13 +13).

  • Continuation in bear market: Downtrend continues after a consolidation or pullback. Hold or add to short positions.
  • Trending down: The RSI is trending down. -1
Island Pharmaceuticals Ltd Daily Relative Strength Index (RSI) ChartIsland Pharmaceuticals Ltd Daily Relative Strength Index (RSI) Chart
3.2 Stochastic Oscillator

Compares a certain price to multiple prices ranging over time.

  • Leading momentum indicator, meaning the signals are instant.
  • Used to determine overbought and oversold areas much like the RSI.
  • Ranges between 0 and 100.
  • Above 80 is considered overbought.
  • Below 20 is considered oversold.
  • Consists of two lines named K and D.
  • K compares the highest high and lowest low on the selected price range.
  • The D line is a moving average of the K line.
  • Can be used to spot divergences

Score

Let's take a look at the Stochastic Oscillator of Island Pharmaceuticals Ltd. The current phase is Continuation in bear market.

The long score for the Stochastic Oscillator is 0/6.
The longshort score for the Stochastic Oscillator is -4/(-6 +6).

  • STOCH < 50: The STOCH %K is below 50. There are more sellers than buyers. -1
  • STOCH %K line < STOCH %D line: The STOCH %K line is below the STOCH %D line, which indicates a bearish signal in the market. This means that the negative momentum is currently stronger than the average momentum, suggesting that sellers are more active than buyers, and there's a higher probability of the Island Pharmaceuticals Ltd price going down in the near term. -2
  • Trending down: The STOCH %K is trending down. -1
Island Pharmaceuticals Ltd Daily Stochastic Oscillator ChartIsland Pharmaceuticals Ltd Daily Stochastic Oscillator Chart
3.3 Commodity Channel Index (CCI)

Measures the difference between the current price and the historical average price.

  • Lagging or leading Momentum indicator
  • When the CCI is above zero, the price is above the historical average
  • When the CCI is below zero, the price is below the historical average
  • Used for spotting trends
    • If the CCI moves from negative or near zero to positive 100 that might indicate an uptrend
    • If the CCI moves from positive or near zero to negative -100 that might indicate a downtrend

Score

Let's take a look at the Commodity Channel Index (CCI) of Island Pharmaceuticals Ltd. The current cci is 14.42.

Island Pharmaceuticals Ltd Daily Commodity Channel Index (CCI) ChartIsland Pharmaceuticals Ltd Daily Commodity Channel Index (CCI) Chart
3.4 Chande Momentum Oscillator (CMO)

Measures the difference between the sum of recent gains and the sum of recent losses. Then divides the result by the sum of all price movements in that period.

  • Lagging momentum indicator
  • Ranges between +100 and -100
  • Considered overbought above +50
  • Considered oversold below -50
  • It's possible to add a moving average that acts as a signal line

Score

Let's take a look at the Chande Momentum Oscillator (CMO) of Island Pharmaceuticals Ltd. The current cmo is -12.02737349.

The long score for the Chande Momentum Oscillator (CMO) is 0/1.
The longshort score for the Chande Momentum Oscillator (CMO) is -1/(-1 +1).

  • CMO < 0: The CMO is below 0, the momentum of the price is negative, indicating a potential downtrend in the price. -1
Island Pharmaceuticals Ltd Daily Chande Momentum Oscillator (CMO) ChartIsland Pharmaceuticals Ltd Daily Chande Momentum Oscillator (CMO) Chart
3.5 Williams %R

 Shows the current price relative to the highest high over the last 14 days.
 

  • Lagging momentum indicator
  • Ranging between 0 and -100
  • Above -20 is considered overbought
  • Below -80 is considered oversold
  • Is prone to give false signals

Score

Let's take a look at the Williams %R of Island Pharmaceuticals Ltd. The current willr is -53.33333333.

The long score for the Williams %R is 0/1.
The longshort score for the Williams %R is 0/(-1 +1).

  • WILLR between -80 and -20: The Williams %R is between -80 and -20. This indicates that Island Pharmaceuticals Ltd is trading in a neutral price range, neither oversold nor overbought, suggesting a balanced market condition without any extreme price signals.
Island Pharmaceuticals Ltd Daily Williams %R ChartIsland Pharmaceuticals Ltd Daily Williams %R Chart

4. Volatility Indicators

4.1 Bollinger Bands

Shows if the price is to high or to low relative to an average.

  • Lagging volatility indicator
  • Uses 3 bands: one upper, one lower and one in the middle
  • Works best when the middle band reflects an intermediate trend (MA20).
  • When the price is moving closer to the upper band, the market might be overbought
  • When the price is moving closer to the lower band, the market might be oversold 

Score

Let's take a look at the Bollinger Bands of Island Pharmaceuticals Ltd.

Island Pharmaceuticals Ltd Daily Bollinger Bands Chart
4.2 Average True Range (ATR)
Measures market volatility
  • Leading volatility indicator
  • Can be used to determine stop-loss positions
  • Calculated by:
    • Current high minus the current low
    • Current high minus the previous close
    • Current low minus the previous close
  • The larger the range of the candles, the greater the ATR value

Score

Let's take a look at the Average True Range (ATR) of Island Pharmaceuticals Ltd. The current atr is 0.00297112.

Island Pharmaceuticals Ltd Daily Average True Range (ATR) ChartIsland Pharmaceuticals Ltd Daily Average True Range (ATR) Chart

5. Volume Indicators

5.1 On-Balance Volume (OBV)

 Measures market volatility

  • Leading momentum indicator
  • Calculation:
    • If the closing price is above the previous closing price: OBV = previous OBV + current volume
    • If the closing price is below the previous closing price: OBV = previous OBV - current volume
    • If the closing price is the same as the previous closing price than the OBV is the same.
  • Can be used to confirm price trends
  • Can be used with divergences

Score

Let's take a look at the On-Balance Volume (OBV) of Island Pharmaceuticals Ltd. The current obv is -700,823.

Island Pharmaceuticals Ltd Daily On-Balance Volume (OBV) ChartIsland Pharmaceuticals Ltd Daily On-Balance Volume (OBV) Chart
5.2 Money Flow Index (MFI)

Measures the flow of money in and out of a security

  • Lagging momentum indicator
  • Looks like RSI but uses volume as an extra metric (RSI only considers price)
  • Above 80 is considered overbought
  • Below 20 is considered oversold
  • Can be used with divergences

Score

Let's take a look at the Money Flow Index (MFI) of Island Pharmaceuticals Ltd. The current mfi is 29.34.

The long score for the Money Flow Index (MFI) is 0/2.
The longshort score for the Money Flow Index (MFI) is -1/(-2 +2).

  • MFI < 50: -1
Island Pharmaceuticals Ltd Daily Money Flow Index (MFI) ChartIsland Pharmaceuticals Ltd Daily Money Flow Index (MFI) Chart

6. Summary

6.1. Notifications

TypeNotificationDate
PenkeCurrently no notifications for Island Pharmaceuticals Ltd.

6.2. Trading Signals

Below you will find trading signals as the indicator is commonly used. This doesn't mean you should use it that way. Learn from these, but don't use them blindly. I recommend using at least 4 indicators, 1 from each category: trend, momentum, volatility and volume.

DateIndicatorSignal
2023-11-20DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
STOCH SHORT EXITThe %K line crosses above the %D line.
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2023-11-22STOCH LONG EXITThe %K line crosses below the %D line.
2023-11-23DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2023-11-24DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
STOCH SHORT EXITThe %K line crosses above the %D line.
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2023-11-28MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2023-11-29CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2023-12-04SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2023-12-11MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2023-12-13STOCH LONG EXITThe %K line crosses below the %D line.
2023-12-14DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2023-12-18STOCH SHORT EXITThe %K line crosses above the %D line.
2023-12-19STOCH LONG EXITThe %K line crosses below the %D line.
2023-12-20WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2023-12-21DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
2023-12-22STOCH LONG EXITThe %K line crosses below the %D line.
2023-12-28BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2023-12-29RSI SHORT ENTRY LONG CLOSE70 crossover to downside
2024-01-12MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-01-16DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-01-17STOCH SHORT EXITThe %K line crosses above the %D line.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-01-18STOCH LONG EXITThe %K line crosses below the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2024-01-19STOCH SHORT EXITThe %K line crosses above the %D line.
2024-01-22ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-01-23CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-01-25DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
2024-01-29WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-01-30MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
2024-01-31MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
STOCH LONG EXITThe %K line crosses below the %D line.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-02-02DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-02-06ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-02-08WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-02-09STOCH SHORT EXITThe %K line crosses above the %D line.
2024-02-13CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-02-15MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
STOCH LONG EXITThe %K line crosses below the %D line.
2024-02-16MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-02-19CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-02-26ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2024-02-28DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
RSI LONG ENTRY SHORT CLOSE30 crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-02-29DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
STOCH LONG EXITThe %K line crosses below the %D line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-03-01CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2024-03-04DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
STOCH SHORT EXITThe %K line crosses above the %D line.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-03-05STOCH LONG EXITThe %K line crosses below the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-03-08DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2024-03-11STOCH LONG EXITThe %K line crosses below the %D line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-03-14BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
2024-03-15MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2024-03-18STOCH SHORT EXITThe %K line crosses above the %D line.
2024-03-21DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
RSI LONG ENTRY SHORT CLOSE30 crossover to upside
MFI LONG ENTRY SHORT CLOSE20 crossover to upside
2024-03-22MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-03-25DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2024-03-28STOCH SHORT EXITThe %K line crosses above the %D line.
2024-04-05MFI LONG ENTRY SHORT CLOSE20 crossover to upside
2024-04-08DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-04-09SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
2024-04-11DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).

6.3. Candlestick Patterns

Island Pharmaceuticals Ltd Daily Candlestick Chart
DateCandlestick Pattern

6.4. Technical Score

Let's check the technical score of Island Pharmaceuticals Ltd based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5042.759
Ma 20Greater thanMa 500.062
Ma 50Greater thanMa 1000.073
Ma 100Greater thanMa 2000.078
OpenGreater thanClose0.064
Total1/5 (20.0%)
Penke

Good job! You gained 25 XP and 0   0   10 . What's next:

  • Share my analysis of Island Pharmaceuticals Ltd with someone you think should read this too:
  • Are you bullish or bearish on Island Pharmaceuticals Ltd? Let me know what you think in the comments.
  • Do you want an email if I find something interesting about Island Pharmaceuticals Ltd? Add an email alert using the form below.
  • Join the community if you want to keep your earnings and track your progress: Join the community
  • Is this analysis useful to you? Support me via But Me a Coffee. I'll analyze the stock market faster for you!

Get notifications about Island Pharmaceuticals Ltd

I send you an email if I find something interesting about Island Pharmaceuticals Ltd.


Comments

How you think about this?

Leave a comment

Stay informed about Island Pharmaceuticals Ltd.

Receive notifications about Island Pharmaceuticals Ltd in your mailbox!